信号和转录动态是早期适应致癌性BRAF抑制的基础
Cameron T Flower1, Chunmei Liu2, Hui-Yu Chuang2
1Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Program in Computational and Systems Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Cell systems
|March 21, 2025
概括
药物诱导的适应性限制了抗癌疗法. 这项研究揭示了BRAF抑制剂治疗触发了补偿性SRC家族激酶 (SFK) 信号,这表明联合治疗可以改善黑色素瘤的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 药物诱导的细胞适应是抗癌激酶抑制剂疗法耐药性的关键机制.
- 了解酶抑制后的动态细胞事件对于开发有效的治疗策略至关重要.
研究的目的:
- 解决瘤性BRAF抑制在黑色素瘤细胞后亚细胞事件的规模和动力学.
- 确定促进药物耐受性和细胞循环再进入的适应性信号网络.
主要方法:
- 利用基于质谱的蛋白组学和RNA测序 (RNA-seq) 来动态监测数千个与生长和生存相关的信号.
- 在人类黑色素瘤细胞中瘤性BRAF抑制后的几分钟,几个小时和几天内分析了数据.
主要成果:
- 观察到BRAF-ERK通路的持续抑制和细胞循环信号的逐渐下调.
- 确定了三种不同的,可逆的相位过渡向细胞静止.
- 揭示了SRC家族激酶 (SFK) 信号的补偿诱导,部分由活性氧物种介导.
结论:
- 早期适应信号,特别是SFK诱导,是药物耐受性的关键决定因素.
- 与SFK抑制剂的同时治疗在体外和体内都显示出增强的疗效.
- 评估早期的药物诱导适应信号具有优化癌症治疗的翻译潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K


